Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context

Human Molecular Genetics

Volumn 21, Issue 11, 2012, Pages 2432-2449

  Sancenon, Vicente ^a   Lee, Sue Ann ^a,b   Patrick, Christina ^d   Griffith, Janice ^e   Paulino, Amy ^d   Outeiro, Tiago F ^f   Reggiori, Fulvio ^e   Masliah, Eliezer ^d   Muchowski, Paul J ^a,b,c  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CASEIN KINASE I; RAB PROTEIN;

ARTICLE; CELL MIGRATION; ENDOCYTOSIS; ENDOSOME; EXOCYTOSIS; GENE EXPRESSION; GENOTOXICITY; HUMAN; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; YEAST;

ALPHA-SYNUCLEIN; ANIMALS; CASEIN KINASE I; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHORYLATION; PROTEIN TRANSPORT; YEASTS;

MAMMALIA; MUS;

EID: 84861144992     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds058     Document Type: Article

References (89)

1. Spillantini, M.G. and Goedert, M. (2000) The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann. NY Acad. Sci., 920, 16-27.
2. Ben Gedalya, T., Loeb, V., Israeli, E., Altschuler, Y., Selkoe, D.J. and Sharon, R. (2009) Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling. Traffic, 10, 218-234.
3. Cabin, D.E., Shimazu, K., Murphy, D., Cole, N.B., Gottschalk, W., McIlwain, K.L., Orrison, B., Chen, A., Ellis, C.E., Paylor, R. et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci., 22, 8797-8807.
4. Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O.M. and Sudhof, T.C. (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell, 123, 383-396.
5. Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R.D. and Arancio, O. (2004) alpha-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO J., 23, 4506-4516.
6. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 841.
7. Fujita, Y., Ohama, E., Takatama, M., Al-Sarraj, S. and Okamoto, K. (2006) Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease. Acta Neuropathol., 112, 261-265.
8. Gosavi, N., Lee, H.J., Lee, J.S., Patel, S. and Lee, S.J. (2002) Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem., 277, 48984-48992.
9. Larsen, K.E., Schmitz, Y., Troyer, M.D., Mosharov, E., Dietrich, P., Quazi, A.Z., Savalle, M., Nemani, V., Chaudhry, F.A., Edwards, R.H. et al. (2006) Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci., 26, 11915-11922.
10. Lee, H.J., Khoshaghideh, F., Lee, S. and Lee, S.J. (2006) Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Eur. J. Neurosci., 24, 3153-3162.
11. Thayanidhi, N., Helm, J.R., Nycz, D.C., Bentley, M., Liang, Y. and Hay, J.C. (2010) Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol. Biol. Cell, 21, 1850-1863.
12. Cooper, A.A., Gitler, A.D., Cashikar, A., Haynes, C.M., Hill, K.J., Bhullar, B., Liu, K., Xu, K., Strathearn, K.E., Liu, F. et al. (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science, 313, 324-328.
13. Gitler, A.D., Bevis, B.J., Shorter, J., Strathearn, K.E., Hamamichi, S., Su, L.J., Caldwell, K.A., Caldwell, G.A., Rochet, J.C., McCaffery, J.M. et al. (2008) The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl Acad. Sci. USA, 105, 145-150.
14. Zabrocki, P., Bastiaens, I., Delay, C., Bammens, T., Ghillebert, R., Pellens, K., De Virgilio, C., Van Leuven, F. and Winderickx, J. (2008) Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. Biochim. Biophys. Acta, 1783, 1767-1780.
15. Soper, J.H., Roy, S., Stieber, A., Lee, E., Wilson, R.B., Trojanowski, J.Q., Burd, C.G. and Lee, V.M. (2008) Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell, 19, 1093-1103.
16. Flower, T.R., Clark-Dixon, C., Metoyer, C., Yang, H., Shi, R., Zhang, Z. and Witt, S.N. (2007) YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole for degradation. J. Cell Biol., 177, 1091-1104.
17. Kuwahara, T., Koyama, A., Koyama, S., Yoshina, S., Ren, C.H., Kato, T., Mitani, S. and Iwatsubo, T. (2008) A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. Hum. Mol. Genet., 17, 2997-3009.
18. Liang, J., Clark-Dixon, C., Wang, S., Flower, T.R., Williams-Hart, T., Zweig, R., Robinson, L.C., Tatchell, K. and Witt, S.N. (2008) Novel suppressors of alpha-synuclein toxicity identified using yeast. Hum. Mol. Genet., 17, 3784-3795.
19. van Ham, T.J., Thijssen, K.L., Breitling, R., Hofstra, R.M., Plasterk, R.H. and Nollen, E.A. (2008) C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet., 4, e1000027.
20. Willingham, S., Outeiro, T.F., DeVit, M.J., Lindquist, S.L. and Muchowski, P.J. (2003) Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science, 302, 1769-1772.
21. Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M.S., Shen, J., Takio, K. and Iwatsubo, T. (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol., 4, 160-164.
22. Waxman, E.A. and Giasson, B.I. (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J. Neuropathol. Exp. Neurol., 67, 402-416.
23. Ishii, A., Nonaka, T., Taniguchi, S., Saito, T., Arai, T., Mann, D., Iwatsubo, T., Hisanaga, S., Goedert, M. and Hasegawa, M. (2007) Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: implication for alpha-synucleinopathies. FEBS Lett., 581, 4711-4717.
24. Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P.J. and Haass, C. (2000) Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem., 275, 390-397.
25. Inglis, K.J., Chereau, D., Brigham, E.F., Chiou, S.S., Schobel, S., Frigon, N.L., Yu, M., Caccavello, R.J., Nelson, S., Motter, R. et al. (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J. Biol. Chem., 284, 2598-2602.
26. Pronin, A.N., Morris, A.J., Surguchov, A. and Benovic, J.L. (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem., 275, 26515-26522.
27. Qing, H., Wong, W., McGeer, E.G. and McGeer, P.L. (2009) Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem. Biophys. Res. Commun., 387, 149-152.
28. Sakamoto, M., Arawaka, S., Hara, S., Sato, H., Cui, C., Machiya, Y., Koyama, S., Wada, M., Kawanami, T., Kurita, K. et al. (2009) Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells. Biochem. Biophys. Res. Commun., 384, 378-382.
29. Azeredo da Silveira, S., Schneider, B.L., Cifuentes-Diaz, C., Sage, D., Abbas-Terki, T., Iwatsubo, T., Unser, M. and Aebischer, P. (2009) Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease. Hum. Mol. Genet., 18, 872-887.
30. Chen, L. and Feany, M.B. (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci., 8, 657-663.
31. Gorbatyuk, O.S., Li, S., Sullivan, L.F., Chen, W., Kondrikova, G., Manfredsson, F.P., Mandel, R.J. and Muzyczka, N. (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl Acad. Sci. USA, 105, 763-768.
32. McFarland, N.R., Fan, Z., Xu, K., Schwarzschild, M.A., Feany, M.B., Hyman, B.T. and McLean, P.J. (2009) Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. J. Neuropathol. Exp. Neurol., 68, 515-524.
33. Outeiro, T.F. and Lindquist, S. (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science, 302, 1772-1775.
34. Lewis, M.J., Nichols, B.J., Prescianotto-Baschong, C., Riezman, H. and Pelham, H.R. (2000) Specific retrieval of the exocytic SNARE Snc1p from early yeast endosomes. Mol. Biol. Cell, 11, 23-38.
35. Reggiori, F., Black, M.W. and Pelham, H.R. (2000) Polar transmembrane domains target proteins to the interior of the yeast vacuole. Mol. Biol. Cell, 11, 3737-3749.
36. Reggiori, F. and Pelham, H.R. (2001) Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. EMBO J., 20, 5176-5186.
37. Marchal, C., Dupre, S. and Urban-Grimal, D. (2002) Casein kinase I controls a late step in the endocytic trafficking of yeast uracil permease. J. Cell Sci., 115, 217-226.
38. Marchal, C., Haguenauer-Tsapis, R. and Urban-Grimal, D. (2000) Casein kinase I-dependent phosphorylation within a PEST sequence and ubiquitination at nearby lysines signal endocytosis of yeast uracil permease. J. Biol. Chem., 275, 23608-23614.
39. Panek, H.R., Conibear, E., Bryan, J.D., Colvin, R.T., Goshorn, C.D. and Robinson, L.C. (2000) Identification of Rgp1p, a novel Golgi recycling factor, as a protein required for efficient localization of yeast casein kinase 1 to the plasma membrane. J. Cell Sci., 113, 4545-4555.
40. Rose, K., Rudge, S.A., Frohman, M.A., Morris, A.J. and Engebrecht, J. (1995) Phospholipase D signaling is essential for meiosis. Proc. Natl Acad. Sci. USA, 92, 12151-12155.
41. Chau, K.Y., Ching, H.L., Schapira, A.H. and Cooper, J.M. (2009) Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis. J. Neurochem., 110, 1005-1013.
42. Kragh, C.L., Lund, L.B., Febbraro, F., Hansen, H.D., Gai, W.P., El-Agnaf, O., Richter-Landsberg, C. and Jensen, P.H. (2009) {alpha}-Synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J. Biol. Chem., 284, 10211-10222.
43. Chen, D.C., Yang, B.C. and Kuo, T.T. (1992) One-step transformation of yeast in stationary phase. Curr. Genet., 21, 83-84.
44. Veal, E.A., Ross, S.J., Malakasi, P., Peacock, E. and Morgan, B.A. (2003) Ybp1 is required for the hydrogen peroxide-induced oxidation of the Yap1 transcription factor. J. Biol. Chem., 278, 30896-30904.
45. Witt, S.N. and Flower, T.R. (2006) alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease. FEMS Yeast Res., 6, 1107-1116.
46. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. and Mucke, L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science, 287, 1265-1269.
47. Rockenstein, E., Mallory, M., Mante, M., Sisk, A. and Masliaha, E. (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J. Neurosci. Res., 66, 573-582.
48. Milne, D.M., Looby, P. and Meek, D.W. (2001) Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization. Exp. Cell Res., 263, 43-54.
49. Yu, S. and Roth, M.G. (2002) Casein kinase I regulates membrane binding by ARF GAP1. Mol. Biol. Cell, 13, 2559-2570.
50. Yasojima, K., Kuret, J., DeMaggio, A.J., McGeer, E. and McGeer, P.L. (2000) Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Res., 865, 116-120.
51. Darios, F., Ruiperez, V., Lopez, I., Villanueva, J., Gutierrez, L.M. and Davletov, B. (2010) Alpha-Synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep., 11, 528-533.
52. Garcia-Reitbock, P., Anichtchik, O., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B., Della Corte, R., Spano, P., Tofaris, G.K., Goedert, M. and Spillantini, M.G. (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain, 133, 2032-2044.
53. Mumberg, D., Muller, R. and Funk, M. (1994) Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res., 22, 5767-5768.
54. Mumberg, D., Muller, R. and Funk, M. (1995) Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene, 156, 119-122.
55. Lafourcade, C., Galan, J.M., Gloor, Y., Haguenauer-Tsapis, R. and Peter, M. (2004) The GTPase-activating enzyme Gyp1p is required for recycling of internalized membrane material by inactivation of the Rab/Ypt GTPase Ypt1p. Mol. Cell. Biol., 24, 3815-3826.
56. Luo, Z. and Gallwitz, D. (2003) Biochemical and genetic evidence for the involvement of yeast Ypt6-GTPase in protein retrieval to different Golgi compartments. J. Biol. Chem., 278, 791-799.
57. Dalfo, E., Barrachina, M., Rosa, J.L., Ambrosio, S. and Ferrer, I. (2004) Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Neurobiol. Dis., 16, 92-97.
58. Dalfo, E. and Ferrer, I. (2005) Alpha-synuclein binding to rab3a in multiple system atrophy. Neurosci. Lett., 380, 170-175.
59. Nakamura, S., Kawamoto, Y., Nakano, S. and Akiguchi, I. (2000) Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy. Clin. Neuropathol., 19, 51-56.
60. Forno, L.S. and Norville, R.L. (1976) Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol., 34, 183-197.
61. Watanabe, I., Vachal, E. and Tomita, T. (1977) Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study. Acta Neuropathol., 39, 173-175.
62. Stenmark, H. and Olkkonen, V.M. (2001) The Rab GTPase family. Genome Biol., 2, REVIEWS3007.
63. van der Sluijs, P., Hull, M., Webster, P., Male, P., Goud, B. and Mellman, I. (1992) The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell, 70, 729-740.
64. Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J.M., Brech, A., Callaghan, J., Toh, B.H., Murphy, C., Zerial, M. and Stenmark, H. (1998) EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature, 394, 494-498.
65. Stenmark, H., Parton, R.G., Steele-Mortimer, O., Lutcke, A., Gruenberg, J. and Zerial, M. (1994) Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J., 13, 1287-1296.
66. Hirai, Y., Fujita, S.C., Iwatsubo, T. and Hasegawa, M. (2004) Phosphorylated alpha-synuclein in normal mouse brain. FEBS Lett., 572, 227-232.
67. Flower, T.R., Chesnokova, L.S., Froelich, C.A., Dixon, C. and Witt, S.N. (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J. Mol. Biol., 351, 1081-1100.
68. Griffioen, G., Duhamel, H., Van Damme, N., Pellens, K., Zabrocki, P., Pannecouque, C., van Leuven, F., Winderickx, J. and Wera, S. (2006) A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential. Biochim. Biophys. Acta, 1762, 312-318.
69. Faundez, V.V. and Kelly, R.B. (2000) The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Ialpha-like isoform. Mol. Biol. Cell, 11, 2591-2604.
70. Bennett, M.K., Miller, K.G. and Scheller, R.H. (1993) Casein kinase II phosphorylates the synaptic vesicle protein p65. J. Neurosci., 13, 1701-1707.
71. Davletov, B., Sontag, J.M., Hata, Y., Petrenko, A.G., Fykse, E.M., Jahn, R. and Sudhof, T.C. (1993) Phosphorylation of synaptotagmin I by casein kinase II. J. Biol. Chem., 268, 6816-6822.
72. Krantz, D.E., Peter, D., Liu, Y. and Edwards, R.H. (1997) Phosphorylation of a vesicular monoamine transporter by casein kinase II. J. Biol. Chem., 272, 6752-6759.
73. Sikorski, R.S. and Hieter, P. (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics, 122, 19-27.
74. Mari, M., Griffith, J., Rieter, E., Krisnappa, L., Klionsky, D.J. and Reggiori, F. (2010) An Atg9-containing compartment that functions in the early steps of autophagosome biogenesis. J. Cell Biol., 190, 1005-1022.
75. Brachmann, C.B., Davies, A., Cost, G.J., Caputo, E., Li, J., Hieter, P. and Boeke, J.D. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast, 14, 115-132.
76. Tong, A.H., Evangelista, M., Parsons, A.B., Xu, H., Bader, G.D., Page, N., Robinson, M., Raghibizadeh, S., Hogue, C.W., Bussey, H. et al. (2001) Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science, 294, 2364-2368.
77. Gietz, R.D., Schiestl, R.H., Willems, A.R. and Woods, R.A. (1995) Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast, 11, 355-360.
78. Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T. et al. (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron, 46, 857-868.
79. Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M. and Mucke, L. (2001) Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl Acad. Sci. USA, 98, 12245-12250.
80. Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C.W., Lang, I. and Masliah, E. (2002) Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J. Neurosci. Res., 68, 568-578.
81. Hansen, L.A., Daniel, S.E., Wilcock, G.K. and Love, S. (1998) Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J. Neurol. Neurosurg. Psychiatry, 64, 653-656.
82. Hansen, L.A., Masliah, E., Quijada-Fawcett, S. and Rexin, D. (1991) Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies. Neurosci. Lett., 129, 269-272.
83. Braak, H. and Braak, E. (1991) Morphological changes in the human cerebral cortex in dementia. J. Hirnforsch., 32, 277-282.
84. McKeith, I.G., Galasko, D., Kosaka, K., Perry, E.K., Dickson, D.W., Hansen, L.A., Salmon, D.P., Lowe, J., Mirra, S.S., Byrne, E.J. et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113-1124.
85. Griffith, J., Mari, M., De Maziere, A. and Reggiori, F. (2008) A cryosectioning procedure for the ultrastructural analysis and the immunogold labelling of yeast Saccharomyces cerevisiae. Traffic, 9, 1060-1072.
86. Slot, J.W. and Geuze, H.J. (2007) Cryosectioning and immunolabeling. Nat. Protoc., 2, 2480-2491.
87. Giaever, G., Chu, A.M., Ni, L., Connelly, C., Riles, L., Veronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., Andre, B. et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature, 418, 387-391.
88. Novick, P., Field, C. and Schekman, R. (1980) Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway. Cell, 21, 205-215.
89. Thomas, B.J. and Rothstein, R. (1989) The genetic control of direct-repeat recombination in Saccharomyces: the effect of rad52 and rad1 on mitotic recombination at GAL10, a transcriptionally regulated gene. Genetics, 123, 725-738.